This is in partial agreement with Debruyer et al., 2010, indicating that delta opioid receptor (DOR) agonists can differentially affect migration of HCT-8/E11 human being
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor